thyroid cancer and tirzepatide Tirzepatide—Friend or Foe in Diabetic Patients? Possible pro-oncogenic effect of tirzepatide

Clinical trials show tirzepatide produced average weight loss of 22.5% at the highest doses (15mg weekly) compared to 12% at lower doses in patients with obesity

RELATED STORY | FDA says shortage of popular diabetes, weight-loss drugs resolved For now though, according to the recent court filing, the FDA said it will not take action against the pharmacies making the drug while it looks into potentially adding it back to its shortage list

Alcohol use disorder causes about 5% of deaths worldwide, according to the World Health Organization

These pleiotrophic effectswhere one drug influences multiple biological targetsexplain why GLP-1 agonists have shown cardiovascular benefit even in patients whose weight loss is modest

Prioritize sleep and hydration, which are both linked to better appetite regulation and higher energy levels